Literature DB >> 11667862

Cyclization of all-L-Pentapeptides by Means of 1-Hydroxy-7-azabenzotriazole-Derived Uronium and Phosphonium Reagents.

Angelika Ehrlich1, Hans-Ulrich Heyne, Rüdiger Winter, Michael Beyermann, Hanka Haber, Louis A. Carpino, Michael Bienert.   

Abstract

Due to their restricted conformational flexibility, cyclic peptides are of great interest in connection with structure-activity relationships, especially the elucidation of bioactive conformations. For linear peptides that do not contain turn structure-inducing amino acid residues, the cyclization reaction may be an inherently improbable or slow process, and side reactions, such as cyclodimerization and epimerization at the C-terminal residue, may dominate. A number of 1-hydroxy-7-azabenzotriazole-based onium salts were examined for cyclization of thymopentin-derived pentapeptides and the results compared with data from more conventional coupling reagents. The azabenzotriazol-derived coupling reagents stood out as being the most effective by far. The cyclizations proceed extremely rapidly, and in contrast to other coupling reagents, C-terminal epimerization was generally less than 10%. C-terminal D-amino acid residues favor the formation of monocyclic pentapeptide rings. A similar effect was observed for cyclization of linear N-methylamino acid-containing peptides, suggesting that reversible amide bond alkylation such as Hmb-modification should be useful in promoting the cyclization of pepitdes devoid of turn-inducing amino acid residues.

Entities:  

Year:  1996        PMID: 11667862     DOI: 10.1021/jo951108d

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  17 in total

Review 1.  Exploring privileged structures: the combinatorial synthesis of cyclic peptides.

Authors:  Douglas A Horton; Gregory T Bourne; Mark L Smythe
Journal:  J Comput Aided Mol Des       Date:  2002 May-Jun       Impact factor: 3.686

Review 2.  Exploring privileged structures: the combinatorial synthesis of cyclic peptides.

Authors:  Douglas A Horton; Gregory T Bourne; Mark L Smythe
Journal:  Mol Divers       Date:  2002       Impact factor: 2.943

Review 3.  Contemporary strategies for peptide macrocyclization.

Authors:  Christopher J White; Andrei K Yudin
Journal:  Nat Chem       Date:  2011-06-23       Impact factor: 24.427

4.  Solid-phase synthesis of cyclic hexapeptides wollamides A, B and desotamide B.

Authors:  Lissa S Tsutsumi; Ghee T Tan; Dianqing Sun
Journal:  Tetrahedron Lett       Date:  2017-05-25       Impact factor: 2.415

5.  Synthesis of endolides A and B: naturally occurring N-methylated cyclic tetrapeptides.

Authors:  Emma K Davison; Alan J Cameron; Paul W R Harris; Margaret A Brimble
Journal:  Medchemcomm       Date:  2019-03-05       Impact factor: 3.597

6.  Anthranilic acid-containing cyclic tetrapeptides: at the crossroads of conformational rigidity and synthetic accessibility.

Authors:  Dongyue Xin; Kevin Burgess
Journal:  Org Biomol Chem       Date:  2016-05-13       Impact factor: 3.876

7.  Modeling of peptides containing D-amino acids: implications on cyclization.

Authors:  Austin B Yongye; Yangmei Li; Marc A Giulianotti; Yongping Yu; Richard A Houghten; Karina Martínez-Mayorga
Journal:  J Comput Aided Mol Des       Date:  2009-07-11       Impact factor: 3.686

8.  A convergent synthesis of the proposed structure of antitumor depsipeptide stereocalpin A.

Authors:  Arun K Ghosh; Chun-Xiao Xu
Journal:  Org Lett       Date:  2009-05-07       Impact factor: 6.005

9.  Synthesis of cyclic peptides through direct aminolysis of peptide thioesters catalyzed by imidazole in aqueous organic solutions.

Authors:  Yangmei Li; Austin Yongye; Marc Giulianotti; Karina Martinez-Mayorga; Yongping Yu; Richard A Houghten
Journal:  J Comb Chem       Date:  2009 Nov-Dec

10.  Oxidation of the Cyanobactin Precursor Peptide Is Independent of the Leader Peptide and Operates in a Defined Order.

Authors:  Sisi Gao; Ying Ge; Andrew F Bent; Ulrich Schwarz-Linek; James H Naismith
Journal:  Biochemistry       Date:  2018-09-28       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.